106 related articles for article (PubMed ID: 16698160)
1. A pilot clinical trial of oxcarbazepine in adults with attention-deficit hyperactivity disorder.
Davids E; Kis B; Specka M; Gastpar M
Prog Neuropsychopharmacol Biol Psychiatry; 2006 Aug; 30(6):1033-8. PubMed ID: 16698160
[TBL] [Abstract][Full Text] [Related]
2. A pilot controlled clinical trial of ABT-418, a cholinergic agonist, in the treatment of adults with attention deficit hyperactivity disorder.
Wilens TE; Biederman J; Spencer TJ; Bostic J; Prince J; Monuteaux MC; Soriano J; Fine C; Abrams A; Rater M; Polisner D
Am J Psychiatry; 1999 Dec; 156(12):1931-7. PubMed ID: 10588407
[TBL] [Abstract][Full Text] [Related]
3. ABT-089, a neuronal nicotinic receptor partial agonist, for the treatment of attention-deficit/hyperactivity disorder in adults: results of a pilot study.
Wilens TE; Verlinden MH; Adler LA; Wozniak PJ; West SA
Biol Psychiatry; 2006 Jun; 59(11):1065-70. PubMed ID: 16499880
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
Spencer TJ; Wilens TE; Biederman J; Weisler RH; Read SC; Pratt R
Clin Ther; 2006 Feb; 28(2):266-79. PubMed ID: 16678648
[TBL] [Abstract][Full Text] [Related]
5. The efficacy and safety profile of lisdexamfetamine dimesylate, a prodrug of d-amphetamine, for the treatment of attention-deficit/hyperactivity disorder in children and adults.
Najib J
Clin Ther; 2009 Jan; 31(1):142-76. PubMed ID: 19243715
[TBL] [Abstract][Full Text] [Related]
6. Does OROS-methylphenidate improve core symptoms and deficits in executive function? Results of an open-label trial in adults with attention deficit hyperactivity disorder.
Fallu A; Richard C; Prinzo R; Binder C
Curr Med Res Opin; 2006 Dec; 22(12):2557-66. PubMed ID: 17166338
[TBL] [Abstract][Full Text] [Related]
7. Venlafaxine in adults with attention-deficit/hyperactivity disorder: an open clinical trial.
Findling RL; Schwartz MA; Flannery DJ; Manos MJ
J Clin Psychiatry; 1996 May; 57(5):184-9. PubMed ID: 8626348
[TBL] [Abstract][Full Text] [Related]
8. A randomized pilot study of the efficacy and safety of ABT-089, a novel α4β2 neuronal nicotinic receptor agonist, in adults with attention-deficit/hyperactivity disorder.
Bain EE; Apostol G; Sangal RB; Robieson WZ; McNeill DL; Abi-Saab WM; Saltarelli MD
J Clin Psychiatry; 2012 Jun; 73(6):783-9. PubMed ID: 22795204
[TBL] [Abstract][Full Text] [Related]
9. A randomized, double-blind, placebo-controlled, multicenter study evaluating the efficacy, safety, and tolerability of extended-release metadoxine in adults with attention-deficit/hyperactivity disorder.
Manor I; Ben-Hayun R; Aharon-Peretz J; Salomy D; Weizman A; Daniely Y; Megiddo D; Newcorn JH; Biederman J; Adler LA
J Clin Psychiatry; 2012 Dec; 73(12):1517-23. PubMed ID: 23290324
[TBL] [Abstract][Full Text] [Related]
10. Randomized controlled study of the histamine H3 inverse agonist MK-0249 in adult attention-deficit/hyperactivity disorder.
Herring WJ; Wilens TE; Adler LA; Baranak C; Liu K; Snavely DB; Lines CR; Michelson D
J Clin Psychiatry; 2012 Jul; 73(7):e891-8. PubMed ID: 22901359
[TBL] [Abstract][Full Text] [Related]
11. Double-blind, placebo-controlled study of zinc sulfate in the treatment of attention deficit hyperactivity disorder.
Bilici M; Yildirim F; Kandil S; Bekaroğlu M; Yildirmiş S; Değer O; Ulgen M; Yildiran A; Aksu H
Prog Neuropsychopharmacol Biol Psychiatry; 2004 Jan; 28(1):181-90. PubMed ID: 14687872
[TBL] [Abstract][Full Text] [Related]
12. Functional impairment in adults positively screened for attention-deficit hyperactivity disorder: the role of symptom presentation and executive functioning.
Szuromi B; Bitter I; Czobor P
Compr Psychiatry; 2013 Oct; 54(7):974-81. PubMed ID: 23684546
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of modafinil film-coated tablets in children and adolescents with attention-deficit/hyperactivity disorder: results of a randomized, double-blind, placebo-controlled, flexible-dose study.
Biederman J; Swanson JM; Wigal SB; Kratochvil CJ; Boellner SW; Earl CQ; Jiang J; Greenhill L
Pediatrics; 2005 Dec; 116(6):e777-84. PubMed ID: 16322134
[TBL] [Abstract][Full Text] [Related]
14. Maintenance of efficacy of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder: randomized withdrawal design.
Brams M; Weisler R; Findling RL; Gasior M; Hamdani M; Ferreira-Cornwell MC; Squires L
J Clin Psychiatry; 2012 Jul; 73(7):977-83. PubMed ID: 22780921
[TBL] [Abstract][Full Text] [Related]
15. Psychotherapy of attention deficit hyperactivity disorder in adults--a pilot study using a structured skills training program.
Hesslinger B; Tebartz van Elst L; Nyberg E; Dykierek P; Richter H; Berner M; Ebert D
Eur Arch Psychiatry Clin Neurosci; 2002 Aug; 252(4):177-84. PubMed ID: 12242579
[TBL] [Abstract][Full Text] [Related]
16. Guanfacine extended release in children and adolescents with attention-deficit/hyperactivity disorder: a placebo-controlled trial.
Sallee FR; McGough J; Wigal T; Donahue J; Lyne A; Biederman J;
J Am Acad Child Adolesc Psychiatry; 2009 Feb; 48(2):155-65. PubMed ID: 19106767
[TBL] [Abstract][Full Text] [Related]
17. A double-blind comparison of galantamine hydrogen bromide and placebo in adults with attention-deficit/hyperactivity disorder: a pilot study.
Biederman J; Mick E; Faraone S; Hammerness P; Surman C; Harpold T; Dougherty M; Aleardi M; Spencer T
J Clin Psychopharmacol; 2006 Apr; 26(2):163-6. PubMed ID: 16633145
[TBL] [Abstract][Full Text] [Related]
18. Assessing attention-deficit/hyperactivity disorder in adults: focus on rating scales.
Murphy KR; Adler LA
J Clin Psychiatry; 2004; 65 Suppl 3():12-7. PubMed ID: 15046530
[TBL] [Abstract][Full Text] [Related]
19. Oxcarbazepine in the treatment of borderline personality disorder: a pilot study.
Bellino S; Paradiso E; Bogetto F
J Clin Psychiatry; 2005 Sep; 66(9):1111-5. PubMed ID: 16187767
[TBL] [Abstract][Full Text] [Related]
20. Posttraumatic stress disorder in adult attention-deficit/hyperactivity disorder: clinical features and familial transmission.
Antshel KM; Kaul P; Biederman J; Spencer TJ; Hier BO; Hendricks K; Faraone SV
J Clin Psychiatry; 2013 Mar; 74(3):e197-204. PubMed ID: 23561240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
